Lazard Asset Management LLC Alpine Immune Sciences, Inc. Transaction History

Lazard Asset Management LLC

  • $68.3 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
BUY
$17.75 - $41.6 $37,452 - $87,776
2,110 Added 39.02%
7,518 $298,000
Q4 2023

Feb 14, 2024
BUY
$8.54 - $20.22 $46,184 - $109,349
5,408 New
5,408 $103,000
Q2 2022

Aug 09, 2022
BUY
$6.71 - $9.52 $30,980 - $43,953
4,617 New
4,617 $39,000

Others Institutions Holding ALPN

# of Institutions
2
Shares Held
56.2K
Call Options Held
0
Put Options Held
0
View Full List

About ALPINE IMMUNE SCIENCES, INC.

ALPN Quotes by TradingView
  • Ticker ALPN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 44,006,700
  • Description
  • Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...
More about ALPN
Track This Portfolio

Track Lazard Asset Management LLC Portfolio

Follow Lazard Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lazard Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lazard Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email